Junichiro Irie

4.1k total citations · 1 hit paper
80 papers, 2.2k citations indexed

About

Junichiro Irie is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Junichiro Irie has authored 80 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Molecular Biology and 22 papers in Surgery. Recurrent topics in Junichiro Irie's work include Diabetes Treatment and Management (23 papers), Diabetes Management and Research (21 papers) and Diabetes and associated disorders (19 papers). Junichiro Irie is often cited by papers focused on Diabetes Treatment and Management (23 papers), Diabetes Management and Research (21 papers) and Diabetes and associated disorders (19 papers). Junichiro Irie collaborates with scholars based in Japan, United States and United Kingdom. Junichiro Irie's co-authors include Hiroshi Itoh, Ikuo Kimura, Junki Miyamoto, Satoru Yamada, Keita Watanabe, Mayu Kasubuchi, Xuan Li, Akira Nakajima, William M. Ridgway and Yuehong Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Junichiro Irie

77 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut microbiota confers host resistance to obesity by metabolizing dietary polyunsaturated fatty acids

2019 288 citations Junki Miyamoto, Miki Igarashi et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junichiro Irie Japan	23	854	712	577	418	372	80	2.2k
Yang Song China	25	742 0.9×	454 0.6×	355 0.6×	389 0.9×	498 1.3×	68	2.3k
Yongde Peng China	30	1.0k 1.2×	435 0.6×	935 1.6×	501 1.2×	933 2.5×	117	3.1k
Giuseppe D’Argenio Italy	27	565 0.7×	331 0.5×	316 0.5×	501 1.2×	372 1.0×	48	2.2k
Bon Jeong Ku South Korea	24	1.0k 1.2×	535 0.8×	506 0.9×	283 0.7×	606 1.6×	108	2.6k
Kuppan Gokulakrishnan India	23	607 0.7×	520 0.7×	662 1.1×	186 0.4×	614 1.7×	69	2.0k
Yii‐Der I. Chen United States	25	549 0.6×	421 0.6×	629 1.1×	259 0.6×	539 1.4×	57	2.0k
Akifumi Kushiyama Japan	29	1.2k 1.4×	486 0.7×	595 1.0×	452 1.1×	609 1.6×	98	2.6k
Michele Malaguarnera Italy	23	695 0.8×	529 0.7×	291 0.5×	357 0.9×	758 2.0×	56	2.2k
Yehuda Kamari Israel	24	593 0.7×	324 0.5×	442 0.8×	342 0.8×	587 1.6×	58	2.0k
Anders Gummesson Sweden	22	1.1k 1.2×	782 1.1×	268 0.5×	284 0.7×	476 1.3×	55	2.1k

Countries citing papers authored by Junichiro Irie

Since Specialization

Citations

This map shows the geographic impact of Junichiro Irie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junichiro Irie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junichiro Irie more than expected).

Fields of papers citing papers by Junichiro Irie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junichiro Irie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junichiro Irie. The network helps show where Junichiro Irie may publish in the future.

Co-authorship network of co-authors of Junichiro Irie

This figure shows the co-authorship network connecting the top 25 collaborators of Junichiro Irie. A scholar is included among the top collaborators of Junichiro Irie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junichiro Irie. Junichiro Irie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Toshimitsu, Takayuki & Junichiro Irie. (2025). An update and overview of the various health‐related benefits of probiotics: A focus on clinical trials demonstrating efficacy, tolerability and use in patients with impaired glucose tolerance and type 2 diabetes. Diabetes Obesity and Metabolism. 27(S1). 15–22. 1 indexed citations

Yamaguchi, Shintaro, Yasuhiro Watanabe, Kenji Kaneko, et al.. (2025). Vascular Endothelial NAMPT ‐Mediated NAD ⁺ Biosynthesis Regulates Angiogenesis and Cardiometabolic Functions in Male Mice. Aging Cell. 24(11). e70222–e70222. 1 indexed citations

Yamaguchi, Shintaro, Junichiro Irie, Masanori Mitsuishi, et al.. (2024). Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men. Endocrine Journal. 71(2). 153–169. 10 indexed citations

Chubachi, Shotaro, Junki Miyamoto, Takashi Shimada, et al.. (2024). Impact of smoking on gut microbiota and short-chain fatty acids in human and mice: Implications for COPD. Mucosal Immunology. 18(2). 353–365. 9 indexed citations

Miyamoto, Junki, Hidenori Shimizu, Keiko Hisa, et al.. (2023). Host metabolic benefits of prebiotic exopolysaccharides produced by Leuconostoc mesenteroides. Gut Microbes. 15(1). 2161271–2161271. 45 indexed citations

Kashiwagi, Kazuhiro, Jun Inaishi, Shotaro Kinoshita, et al.. (2023). Assessment of glycemic variability and lifestyle behaviors in healthy nondiabetic individuals according to the categories of body mass index. PLoS ONE. 18(10). e0291923–e0291923. 7 indexed citations

Yoshifuji, Ayumi, et al.. (2023). Canagliflozin protects the cardiovascular system through effects on the gut environment in non-diabetic nephrectomized rats. Clinical and Experimental Nephrology. 27(4). 295–308. 8 indexed citations

Yamaguchi, Shintaro, Koichiro Homma, Kazutoshi Miyashita, et al.. (2022). Intestinal Epithelial NAD+ Biosynthesis Regulates GLP-1 Production and Postprandial Glucose Metabolism in Mice. Endocrinology. 163(4). 12 indexed citations

Miyamoto, Junki, Ryuji Ohue‐Kitano, Akari Nishida, et al.. (2019). Ketone body receptor GPR43 regulates lipid metabolism under ketogenic conditions. Proceedings of the National Academy of Sciences. 116(47). 23813–23821. 92 indexed citations

10.

Miyamoto, Junki, Miki Igarashi, Keita Watanabe, et al.. (2019). Gut microbiota confers host resistance to obesity by metabolizing dietary polyunsaturated fatty acids. Nature Communications. 10(1). 4007–4007. 288 indexed citations breakdown →

11.

Miyamoto, Junki, Keita Watanabe, Satsuki Taira, et al.. (2018). Barley β-glucan improves metabolic condition via short-chain fatty acids produced by gut microbial fermentation in high fat diet fed mice. PLoS ONE. 13(4). e0196579–e0196579. 114 indexed citations

12.

Meguro, Shu, et al.. (2018). Difference of seasonal variation between glycated albumin and glycated haemoglobin. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 55(5). 583–587. 8 indexed citations

13.

Irie, Junichiro, M. Kato, Kumiko Tanaka, et al.. (2017). GLP-1 receptor agonist, liraglutide, ameliorates hepatosteatosis induced by anti-CD3 antibody in female mice. Journal of Diabetes and its Complications. 31(9). 1370–1375. 8 indexed citations

14.

Nakajima, Akira, Sae Hasegawa, Junichiro Irie, et al.. (2017). The short chain fatty acid receptor GPR43 regulates inflammatory signals in adipose tissue M2-type macrophages. PLoS ONE. 12(7). e0179696–e0179696. 110 indexed citations

15.

Yamada, Satoru, et al.. (2015). A comparison study of patient ratings and safety of 32- and 34-gauge insulin pen needles. Diabetology International. 7(3). 259–265. 4 indexed citations

16.

Irie, Junichiro, et al.. (2012). Bile acid binding resin shows anti-obese effect through the modifications of intestinal microbiota. 15th International & 14th European Congress of Endocrinology. 29. 1 indexed citations

17.

Kawai, Toshihide, Izumi Takei, Akira Shimada, et al.. (2010). Effects of Olmesartan Medoxomil, an Angiotensin II Type 1 Receptor Antagonist, on Plasma Concentration of B-Type Natriuretic Peptide, in Hypertensive Patients with Type 2 Diabetes Mellitus. Clinical Drug Investigation. 31(4). 237–245. 4 indexed citations

18.

Irie, Junichiro, Yuehong Wu, Linda S. Wicker, et al.. (2006). NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. The Journal of Experimental Medicine. 203(5). 1209–1219. 141 indexed citations

19.

Oikawa, Yoichi, Akira Shimada, Satoru Yamada, et al.. (2003). NKT Cell Frequency in Japanese Type 1 Diabetes. Annals of the New York Academy of Sciences. 1005(1). 230–232. 11 indexed citations

20.

Shimada, Akira, Keiichi Kodama, Jiro Morimoto, et al.. (2003). Detection of GAD‐Reactive CD4+ Cells in So‐Called “Type 1B” Diabetes. Annals of the New York Academy of Sciences. 1005(1). 378–386. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact